FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke
Posted
Frank Vinluan (via MedCity News)
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults.
The post FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke appeared first on MedCity News.
